跳至主要内容
临床试验/JPRN-UMIN000014769
JPRN-UMIN000014769已完成未知

Add-on effects of tadalafil for tamsulosin treated patients with benign prostatic hyperplasia suffering from residual lower urinary tract symptoms: a randomized, placebo-controlled, double-blind, crossover study - Add-on effects of tadalafil for tamsulosin treated patients with residual LUTS: a randomized, placebo-controlled, double-blind, crossover study

Department of Urology, Kyoto University, Graduate School of Medicine0 个研究点目标入组 40 人开始时间: 2014年10月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50years-old 至 ot applicable(—)
性别
Male

入选标准

  • 未提供

排除标准

  • 1) Patients with prostate cancer, neurogenic bladder, urethral stricture, chronic prostatitis, urinary tract infections, urinary tract stones or interstitial cystitis. 2) Patients with a contraindication for tadarafil 3) Patients taking silodosin or naftopidil, or in 2 weeks after stopping those two. 4) Patients taking dutasteride, or in 3 months after stopping dutasteride. 5) Patients taking anticholinergics, or in 2 weeks after stopping them. 6) Patients who are diagnosed as not applicable to this study by an attending doctor.

研究者

发起方
Department of Urology, Kyoto University, Graduate School of Medicine

相似试验